Oragenics Files 8-K with Financials and Exhibits
Ticker: OGEN · Form: 8-K · Filed: Jan 21, 2025 · CIK: 1174940
Sentiment: neutral
Topics: sec-filing, financials, exhibits
Related Tickers: ORGN
TL;DR
ORGN filed an 8-K for routine financials/exhibits. No major news.
AI Summary
On January 21, 2025, Oragenics, Inc. filed an 8-K report. The filing primarily concerns the submission of financial statements and exhibits, indicating routine corporate activity rather than a specific material event. No new material agreements, executive changes, or significant financial transactions were detailed in the provided excerpt.
Why It Matters
This filing indicates Oragenics is meeting its routine reporting obligations with the SEC, which is standard for publicly traded companies. It does not signal a new development but rather ongoing compliance.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for financial statements and exhibits, indicating routine corporate compliance rather than a significant event or risk.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- January 21, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for Oragenics, Inc.?
The primary purpose of this 8-K filing is to report Other Events and to submit Financial Statements and Exhibits.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported is January 21, 2025.
What is Oragenics, Inc.'s state of incorporation?
Oragenics, Inc. is incorporated in Florida (FL).
What is the IRS Employer Identification Number for Oragenics, Inc.?
The IRS Employer Identification Number for Oragenics, Inc. is 59-3410522.
What is the principal executive office address for Oragenics, Inc.?
The principal executive office address is 1990 Main Street, Suite 750, Sarasota, FL 34236.
Filing Stats: 445 words · 2 min read · ~1 pages · Grade level 11.2 · Accepted 2025-01-21 08:00:25
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 28KB
- 0001493152-25-002928.txt ( ) — 246KB
- ogen-20250121.xsd (EX-101.SCH) — 3KB
- ogen-20250121_lab.xml (EX-101.LAB) — 33KB
- ogen-20250121_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 21 st day of January 2025. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer